dijous, 9 de febrer de 2017 · International workshop

Translating Colorectal Cancer Research

Portuguese Oncology Institute (IPO-Porto), Porto, Portugal.
Presentat per:
Manuel Teixeira (IPO-Porto, Porto, Portugal) Sergi Castellví-Bel (IDIBAPS, Barcelona, Spain) Thomas Reid (National Cancer Institute, Bethesda, USA) Jordi Camps (IDIBAPS, Barcelona, Spain)

Colorectal cancer is a major public health concern, ranking among the leading causes of cancer death in both men and women. Because of this continued burden there is a clear need for improved treatment, and more importantly prevention, of this disease. The word ‘translate’ has its origins in the Latin word translatio, meaning 'to carry across'. Accordingly, translational research is focused on carrying discoveries from the laboratory bench to the bedside of the patient. Nowhere is translational medicine making more spectacular gains for patient welfare than in cancer. This field is rapidly progressing along with the advance in cutting-edge laboratory technologies such as next generation sequencing. This 2-day international workshop aims at providing a dedicated forum for the latest approaches used in colorectal cancer research and its translation into improving patient’s life.

Confirmed Speakers
Sabrina Arena (Bardelli’s group, Candiolo Cancer Institute, Torino, Italy)
René Bernards (Netherlands Cancer Institute, Amsterdam, Netherlands)
Evelien Dekker (Academic Medical Centre, Amsterdam, Netherlands)
Marc Gunter (EPIC consortium, International Agency for Research on Cancer, Lyon, France)
Kari Hemminki (German Cancer Research Center, Heidelberg, Germany)
Roland Kuiper (Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands)
Gerrit Meijer (Netherlands Cancer Institute, Amsterdam, Netherlands)
Noel de Miranda (Leiden University Medical Center, Leiden, Netherlands)
Ulrike Peters (GECCO consortium, Fred Hutchinson Cancer Research Center, Seattle, USA)
Thomas Reid (National Cancer Institute, Bethesda, USA)
Zoltan Szallasi (Dana-Farber/Harvard Cancer Center, Boston, USA)
Daniele Tauriello (Batlle’s group, Institute for Research in Biomedicine, Barcelona, Spain)
Ian Tomlinson (Welcome Trust Centre for Human Genetics, Oxford, United Kingdom)
Haiyuan Yu (Cornell University, Ithaca, USA)